Scientific Publications

  1. Balakrishnan R, Subbarayan R*, Shrestha R*, Chauhan A, Krishnamoorthy L. Exploring platelet-derived microvesicles in vascular regeneration: unraveling the intricate mechanisms and molecular mediators. Mol Biol Rep. 2024 Mar 6;51(1):393. doi: 10.1007/s11033-024-09302-1. PMID: 38446325.
  2. Liu W, Shrestha R, Lowe A, Zhang X, Spaeth L. Self-formation of concentric zones of telencephalic and ocular tissues and directional retinal ganglion cell axons. Elife. 2023 Sep 4;12:RP87306. doi: 10.7554/eLife.87306. PMID: 37665325.
  3. Ferrena A*, Zhang X*, Shrestha R*, Zheng D, Liu W. Six3 and Six6 jointly regulate the identities and developmental trajectories of multipotent retinal progenitor cells in the mouse retina. bioRxiv [Preprint]. 2023 May 3:2023.05.03.539288. DOI: 10.1101/2023.05.03.539288.
  4. Shrestha R, Shrestha R, Khadka RB, Gyawali R. Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection. JNMA J Nepal Med Assoc. 2021 Jul 30;59(239):727-729doi: 10.31729/jnma.5538. PMID: 34508515.
  5. Shrestha R, Wen YT, Tsai RK. Effective Differentiation and Biological Characterization of Retinal Pigment Epithelium Derived from Human Induced Pluripotent Stem Cells. Curr Eye Res. 2020 Sep;45(9):1155-1167doi: 10.1080/02713683.2020.1722180. PMID: 31984806.
  6. Shrestha R. Induced pluripotent stem cells are Japanese brand sources for therapeutic cells to pretrial clinical research. Progress in Stem Cell2020 June7(1):296-303doi: 10.15419/psc.v7i1.409.
  7. Shrestha R, Wen YT, Tsai RK. Induced pluripotent stem cells and derivative photoreceptor precursors as therapeutic cells for retinal degenerations. Ci Ji Yi Xue Za Zhi. 2020 Apr-Jun;32(2):101-112doi: 10.4103/tcmj.tcmj_147_19. PMID: 32269941; PMCID: PMC7137374.
  8. Shrestha R, Wen YT, Tsai RK. Generation of hiPSC line TCIERi001-A from normal human epidermal keratinocytes. Stem Cell Res. 2019 Dec;41:101590doi: 10.1016/j.scr.2019.101590. PMID: 31683100.
  9. Khadka S*, Shrestha R*, Pandit S, Pandit R, Bastola A. Late Response of Antiretroviral Therapy in an HIV-1-Infected Patient due to Hepatitis B and C Coinfections: The First Case Report in Nepal. Case Rep Med. 2019;2019:2070973doi: 10.1155/2019/2070973. PMID: 30886633;  PMCID: PMC6388324.
  10. Shrestha R, Wen YT, Ding DC, Tsai RK. Aberrant hiPSCs-Derived from Human Keratinocytes Differentiates into 3D Retinal Organoids that Acquire Mature Photoreceptors. Cells2019 Jan 9;8(1)doi: 10.3390/cells8010036. PMID: 30634512; PMCID: PMC6356277.
  11. Shrestha R, Palat A, Punnoose AM, Joshi S, Ponraju D, Paul SF. Electrospun cellulose acetate phthalate nanofibrous scaffolds fabricated using novel solvent combinations biocompatible for primary chondrocytes and neurons. Tissue Cell2016 Dec;48(6):634-643doi: 10.1016/j.tice.2016.07.007. PMID: 27546071.
  12. Shrestha R, Palat A, Anbarasan S, Paul S. Variation in growth pattern and morphological appearance of primary monolayer cultures of chondrocytes and neural cells isolated from the chick embryo at different stages. Acta Medica International. 20152(2):61-67doi: 10.5530/ami.2015.3.3.

Online News Portal Publications

  1. Rupendra Shrestha, April 9th, 2020. COVID-19: 50 Facts for Nepal. Disaster, Nature Khabar.
  2. Rupendra Shrestha, November 30th, 2018. First genetically engineered babies made in china: lulu and nana. Science and Technology, Nature Khabar.
  3. Rupendra Shrestha, July 17th, 2017. First 3D structures of active DNA: update on world DNA day. Science and Technology, Nature Khabar.
  4. Rupendra Shrestha, April 25th, 2017. DNA data storage: movie encoded in the genomes of living bacteria. Science and Technology, Nature Khabar.
  5. Rupendra Shrestha, April 15th, 2017. World’s first baby with three genetic parents: DNA breakthrough. Science and Technology, Nature Khabar.
  6. Rupendra Shrestha, April 11th, 2017. Molecular genetic testing: prominence and facilities in Nepal. Science and Technology, Nature Khabar.